A. Chlistalla

1.1k total citations · 1 hit paper
7 papers, 825 citations indexed

About

A. Chlistalla is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A. Chlistalla has authored 7 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in A. Chlistalla's work include Cancer Treatment and Pharmacology (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). A. Chlistalla is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). A. Chlistalla collaborates with scholars based in United Kingdom, Germany and Switzerland. A. Chlistalla's co-authors include Nadia Harbeck, Guenther G. Steger, David Miles, Joohyuk Sohn, Arlene Chan, Gilles Romieu, Andreas Schneeweiß, Louise Provencher, Luc Dirix and T. Delozier and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

A. Chlistalla

7 papers receiving 799 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

2010 700 citations David Miles, Arlene Chan et al. Journal of Clinical Oncology profile →

Peers

A. Chlistalla

ONCOL

CR

MB

PRM

CCM

B. Salvadori Italy

Xiaohong Yan United States

James A. Onori United States

Daniela Morales-Espinosa Spain

Valeria Merz Italy

F. De Vita Italy

Eleonora Nicolò Italy

Tetsukan Woo Japan

Nathalie Voorzanger‐Rousselot France

Carla Castanaro United States

B. Salvadori Italy

A. Chlistalla

547 ×0.9

ONCOL

340 ×1.3

CR

115 ×0.5

MB

166 ×0.9

PRM

145 ×1.3

CCM

Citations per year, relative to A. Chlistalla A. Chlistalla (= 1×) peers B. Salvadori

Countries citing papers authored by A. Chlistalla

Since Specialization

Citations

This map shows the geographic impact of A. Chlistalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Chlistalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Chlistalla more than expected).

Fields of papers citing papers by A. Chlistalla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Chlistalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Chlistalla. The network helps show where A. Chlistalla may publish in the future.

Co-authorship network of co-authors of A. Chlistalla

This figure shows the co-authorship network connecting the top 25 collaborators of A. Chlistalla. A scholar is included among the top collaborators of A. Chlistalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Chlistalla. A. Chlistalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Miles, David, Arlene Chan, Luc Dirix, et al.. (2010). Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer. Journal of Clinical Oncology. 28(20). 3239–3247. 700 indexed citations breakdown →

2.

Smith, IE, Laura Biganzoli, H. Cortés-Funes, et al.. (2009). Primary analysis of study MO19391, an open-label safety study of bevacizumab (B) plus taxane-based therapy as 1st-line treatment of patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC).. Cancer Research. 69(2_Supplement). 4118–4118. 5 indexed citations

3.

Harbeck, Nadia, Alexandre Chan, Daan ten Bokkel Huinink, et al.. (2009). No Clinical Evidence for Increase in Tumour Malignant Potential in Patients (Pts) with Metastatic Breast Cancer (mBC) Treated with Bevacizumab (BV) and Docetaxel (D) in the Phase III AVADO Study.. Cancer Research. 69(24_Supplement). 6086–6086. 7 indexed citations

4.

Cortés-Funes, H., Kathleen I. Pritchard, Laura Biganzoli, et al.. (2009). 5017 Multinational study (n = 2041) of first-line bevacizumab (Bev) plus taxane-based chemotherapy (CT) for locally recurrent or metastatic breast cancer (LR/mBC): updated results of MO19391. European Journal of Cancer Supplements. 7(2). 265–266. 6 indexed citations

5.

Morschhauser, F., et al.. (2005). Assessing the Predictive Value of Plasma FLT3-L Levels for Hematologic Toxicity after Yttrium-90 Ibritumomab Tiuxetan ([90Y]-Zevalin) Given as Consolidation in Patients with Advanced B-Cell Follicular NHL Responding to First Line Therapy.. Blood. 106(11). 4795–4795. 2 indexed citations

6.

Ungerer, Martin, Franz Hartmann, A. Chlistalla, et al.. (1998). Regional In Vivo and In Vitro Characterization of Autonomic Innervation in Cardiomyopathic Human Heart. Circulation. 97(2). 174–180. 84 indexed citations

7.

Ungerer, Martin, A. Chlistalla, & Gert Richardt. (1996). Upregulation of Cardiac Uptake₁Carrier in Ischemic and Nonischemic Rat Heart. Circulation Research. 78(6). 1037–1043. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact